You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-VEGF (VEGFA) Anticorps

Full name:
anti-Vascular Endothelial Growth Factor A Anticorps (VEGFA)
Chez www.anticorps-enligne.fr sont 359 Vascular Endothelial Growth Factor A (VEGFA) Anticorps de 33 de différents fournisseurs disponibles. De plus, nous expédions VEGF Protéines (130) et VEGF Kits (111) et beaucoup plus de produits pour cette protéine. Un total de 617 VEGF produits sont actuellement listés.
Synonymes:
eVEGF120, eVEGF164, MVCD1, vefg, Vegf, VEGF-A, Vegf120, VEGF164, Vegf188, vegfa, Vpf, wu:fj82c06

Tous anti-VEGF Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-VEGF Anticorps mieux référencés

  1. Human Polyclonal VEGF Primary Antibody pour EIA, WB - ABIN955508 : Shrivastava-Ranjan, Rollin, Spiropoulou: Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. dans Journal of virology 2010 (PubMed)
    Show all 5 references for ABIN955508

  2. Guinea Pig Polyclonal VEGF Primary Antibody pour IF (p), IHC (p) - ABIN707186 : Wang, Liao, Wang, Deng, Yu: Transplantation of bone marrow stromal cells overexpressing human vascular endothelial growth factor 165 enhances tissue repair in a rat model of radiation-induced injury. dans Chinese medical journal 2014 (PubMed)
    Show all 3 references for ABIN707186

  3. Human Polyclonal VEGF Primary Antibody pour EIA, IHC (p) - ABIN155190 : Breier, Albrecht, Sterrer, Risau: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. dans Development (Cambridge, England) 1992 (PubMed)
    Show all 3 references for ABIN155190

  4. Human Monoclonal VEGF Primary Antibody pour EIA, Func - ABIN155173 : Kim, Li, Houck, Winer, Ferrara: The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. dans Growth factors (Chur, Switzerland) 1992 (PubMed)
    Show all 2 references for ABIN155173

  5. Human Monoclonal VEGF Primary Antibody pour Func - ABIN180646 : Brown, Berse, Jackman, Tognazzi, Guidi, Dvorak, Senger, Connolly, Schnitt: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. dans Human pathology 1995 (PubMed)

  6. Human Polyclonal VEGF Primary Antibody pour IF (p), IHC (p) - ABIN675893 : Ryzhov, Goldstein, Novitskiy, Blackburn, Biaggioni, Feoktistov: Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells. dans The Journal of pharmacology and experimental therapeutics 2012 (PubMed)

  7. Human Monoclonal VEGF Primary Antibody pour FACS - ABIN4898939 : Lee, Myers, Kim: Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. dans American journal of respiratory and critical care medicine 2009 (PubMed)

  8. Human Monoclonal VEGF Primary Antibody pour IHC (p) - ABIN114925 : Turley, Scott, Watts, Bicknell, Harris, Gatter: Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. dans The Journal of pathology 1999 (PubMed)

Plus d’anticorps contre VEGF partenaires d’interaction

Zebrafish Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. altering the amount of VEGF signaling in endothelial cells by stimulating them with different VEGF concentrations triggered distinct and mutually exclusive dynamic Ca(2 (Montrer CA2 Anticorps)+) signaling responses that correlated with different cellular behaviors.

  2. Bis(2,3-dibromo-4,5-dihydroxybenzyl) ether downregulate the expression of VEGF and VEGFR, and simultaneously regulates VEGF signaling pathway to prevent angiogenesis.

  3. noncanonical function of tars (Montrer TARS Anticorps) regulates vascular development presumably by modulating the expression of vegfa

  4. Methylglyoxal acts on smaller blood vessels in zebrafish via the VEGF receptor (Montrer FLT1 Anticorps) signaling cascade, thereby describing a new mechanism that can explain vascular complications under hyperglycemia and elevated MG concentrations.

  5. The translation initiation factor eIF3i (Montrer EIF3I Anticorps) up-regulates VEGF-A, accelerates cell proliferation, and promotes angiogenesis in embryonic development.

  6. lack of SULF1 (Montrer SULF1 Anticorps) expression downregulates VEGFA-mediated arterial marker expression, confirming that Sulf1 (Montrer SULF1 Anticorps) mediates arterial specification by regulating VegfA165 activity.

  7. yolk-derived 17beta-estradiol sets the ventral boundary of hemogenic vascular niche specification by antagonizing the dorsal-ventral regulatory limits of VEGF.

  8. Vegfaa has a crucial role in angiogenesis and vegfaa expression was upregulated in embryos lacking functional Pten (Montrer PTEN Anticorps).

  9. Over expression of zebrafish vegf-a rescues Methyl tert (Montrer TERT Anticorps)-butyl ether induced vascular lesions.

  10. Elevated Notch (Montrer NOTCH1 Anticorps) signaling downstream of perturbed VEGF signaling contributes to aberrant flt-1 (Montrer FLT1 Anticorps)(-/-) blood vessel formation.

Xenopus laevis Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGFA produced in the somites is required to initiate adult haemangioblast programming in the adjacent dorsal lateral plate mesoderm.

  2. sequential, isoform-specific VEGFA signaling successively induces the endothelial, arterial, and hematopoietic stem cell programs in the dorsal aorta.

  3. VEGF induces stromal cell migration or recruitment that are required for blood vessel formation.

  4. increased VEGF(170) levels disturb Hand-1 (Montrer HAND1 Anticorps) expression in the region required for normal heart morphogenesis

Cow (Bovine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  2. Studied the effect of cyclic uniaxial stretch (20%, 1 Hz), with and without the stimulation of vascular endothelial growth factor (VEGF), on sprouting angiogenesis by employing a stretchable three-dimensional cell culture model.

  3. Study shows that VEGFA mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension.

  4. Data indicate that superoxide dismutase (SOD) inhibited high glucose (HG)-induced expression of uPAR and VEGF in bovine retinal microvascular endothelial cell (REC).

  5. Exposure of endothelial cells to VEGF, high glucose, or hydrogen peroxide up-regulated the XBP1 (Montrer XBP1 Anticorps)/IRE1 alpha (Montrer ERN1 Anticorps) and ATF6 (Montrer ATF6 Anticorps) arms of the unfolded protein response compared with untreated cells.

  6. Microvascular endothelial cells are more susceptible than aortic cells to advanced glycation end products-enhanced permeability and that AGE-enhanced permeability is dependent on VEGF expression induced by reactive oxygen species.

  7. VEGF supports germ cell survival and sperm production in bulls.

  8. analysis of polymorphisms of bovine VEGF gene and their associations with growth traits in Chinese cattle

  9. VEGF mRNA expression at estrus was higher than at the early I, early II and late luteal stages (P<0.05), whereas VEGF protein content was greatest at the early I luteal stage and decreased thereafter

  10. Alterations in the expression of VEGF-A and bFGF (Montrer FGF2 Anticorps) systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.

Human Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Varying degrees of immunoreactivity to Cyclin D1 (Montrer CCND1 Anticorps), VEGF, and EZH2 (Montrer EZH2 Anticorps) were noted in the majority of the AT/RTs (Montrer RECQL4 Anticorps), and detection of these markers may be of value in the development of novel therapeutic agents and in determining which patients can benefit from them

  2. VEGF-A165a mRNA expression and VEGF-A protein production were significantly increased after incubation with glyoxal in ARPE-19 cells

  3. VEGF-A driven Mdm2 (Montrer MDM2 Anticorps) phosphorylation on Ser166 is dependent on the ERK1/2 (Montrer MAPK1/3 Anticorps)/p90RSK (Montrer RPS6KA1 Anticorps) signaling pathway in primary human endothelial cells.

  4. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  5. miR (Montrer MLXIP Anticorps)-361-5p is down-regulated in 135 patients with HCV-related hepatocellular carcinoma (HCC (Montrer FAM126A Anticorps)). Moreover, the expressions of miR (Montrer MLXIP Anticorps)-361-5p were highly correlated with VEGFA in these HCC (Montrer FAM126A Anticorps) patients.

  6. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors.

  7. Angiogenesis in Infantile haemangioma (IH) appears to be controlled by DLL4 (Montrer DLL4 Anticorps) within the endothelium in a VEGF-A isoform-dependent manner, and in perivascular cells in a VEGF-independent manner. The contribution of VEGF-A isoforms to disease progression also indicates that IH may be associated with altered splicing.

  8. The encouraging overall survival and favorable safety profile observed with sonepcizumab should prompt further investigation of the agent in combination with VEGF-directed agents or checkpoint inhibitors.

  9. The CRISPR-Cas9 endonuclease system may reduce VEGF-A secretion from human RPE (Montrer RPE Anticorps) cells and suppress angiogenesis, supporting the possibility of employing gene editing for antiangiogenesis therapy in ocular diseases.

  10. Using a combination of cytokine expression profiling and miRNAs algorithms, we identified VEGFA/CCL2 (Montrer CCL2 Anticorps) and FOXO3a (Montrer FOXO3 Anticorps) as direct targets of miR-1 (Montrer FSD1 Anticorps), miR (Montrer MLXIP Anticorps)-206 and miR (Montrer MLXIP Anticorps)-31, respectively. Importantly, systemic delivery of anti-VEGFA/CCL2 (Montrer CCL2 Anticorps) or pre-miR-1 (Montrer FSD1 Anticorps), pre-miR (Montrer MLXIP Anticorps)-206 and anti-miR (Montrer MLXIP Anticorps)-31 significantly inhibited tumor angiogenesis, TAMs accumulation, tumor growth and lung metastasis.

Mouse (Murine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. First-in-class selective PET tracers for imaging VEGFR-1 (Montrer FLT1 Anticorps) and VEGFR-2 (Montrer KDR Anticorps) were constructed and successfully validated in an orthotopic murine tumor model.

  2. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  3. The results demonstrate that the Vegf-Dll4 (Montrer DLL4 Anticorps)/Notch (Montrer NOTCH1 Anticorps) feedback system normally operates to generate heterogeneity between endothelial cells driving blood vessel branching, whilst synchronization drives vessel expansion.

  4. Ginkgo biloba exocarp extract inhibits tumor angiogenesis, which may be closely relevant to its effect in blockage of Wnt /beta-catenin-VEGF signaling pathway in Lewis lung carcinoma.

  5. D2R agonist treatment blocks tumor growth, induces regression of the aberrant blood supply and normalizes blood vessels. An anti-Vegf therapy is also effective to restrain tumor growth and improves vascular remodeling. Importantly, only the combination treatment suppresses intratumoral hemorrhage and restores blood vessel perfusion, suggesting that it might represent an attractive therapy targeting tumor vasculature

  6. VEGF-A mRNA and protein expression were upregulated in choroidal neovascularization; these changes were ameliorated by restoration of miR (Montrer MLXIP Anticorps)-93 by means of transfection.

  7. These results indicate that tensile force induces in vivo gene expression associated with vascularization early in tensile-force-induced sutural bone formation. Moreover, the early induction of Vegf gene expression is regulated by CTGF (Montrer CTGF Anticorps) and ROCK2 (Montrer ROCK2 Anticorps).

  8. Combining VEGF165 obviously enhanced the inducing effects of BMP2 (Montrer BMP2 Anticorps) on osteogenic differentiation capacity of C3H10T1/2 cells.

  9. our results clearly indicate that the two major VEGF isoforms are not redundant in inducing and regulating tumor angiogenesis, as they can exert even opposite effects on the growth and invasion of cancer cells in vivo.

  10. Endothelial cell-specific endoglin expression in islets of Langerhans is sensitive to VEGF and plays partial roles in driving islet vascular development, however such regulation appears to be distinct to mechanisms required to modulate islet viability and size.

Pig (Porcine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Here we demonstrate that VEGF-165 mediates MSC (Montrer MSC Anticorps) differentiation into ECs via VEGFR-2 (Montrer KDR Anticorps)-dependent induction of Sox18 (Montrer SOX18 Anticorps), which ultimately coordinates the transcriptional upregulation of specific markers of the EC phenotype.

  2. VEGF was significantly downregulated 7 days after cryotherapy of the sclera and stayed at that level until day 14. It returned to baseline by day 21.

  3. VEGF production, blood vessel network and follicle remodeling are impaired by the antiprogesterone RU486.

  4. findings suggest that the augmented neovascular response seen with VEGF administration was through the VEGF-induced upregulation of Notch (Montrer NOTCH1 Anticorps) signaling.

  5. interleukin-1beta-induced vascular endothelial growth factor in airway smooth muscle cells

  6. Upregulation of VEGF during hypoxia in chondrocyte is mediated partially through HIF-1alpha (Montrer HIF1A Anticorps).

  7. data shows that members of the VEGF-VEGFR (Montrer KDR Anticorps) system are temporally and spatially well localized for playing key roles during umbilical cord formation and its intensive growth observed after day 75 of pregnancy

  8. cardiac-specific and hypoxia-induced coexpression of VEGF and Ang1 (Montrer ANGPT1 Anticorps) improves the perfusion and function of porcine MI heart through the induction of angiogenesis and cardiomyocyte proliferation

  9. The mRNA for VEGFA was expressed in early developing and in maturing glomeruli.

  10. Data show that subventricular zone neural stem cells express VEGF and all VEGF splice variants, VEGFR1 (Montrer FLT1 Anticorps), VEGFR2 (Montrer KDR Anticorps) and Neuropilin-1 (Montrer NRP1 Anticorps) and -2 mRNAs.

Horse (Equine) Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion

  2. TNF (Montrer TNF Anticorps) may up-regulate VEGF and stimulate angiogenesis in the mare (Montrer C16orf35 Anticorps) early corpus luteum.

Guinea Pig Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. After acoustic trauma, vascular endothelial growth factor was up-regulated both in the cochlea and vestibule. Expression in both structures suggests a reparative role with potentially therapeutic implications.

  2. Studied the role of T help 17 cells (Th17) and STAT3-VEGF pathway in pathogenesis of psoriasis.

Rabbit Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGF mRNA abundance was present at low levels at 16 h post-ovulation and remained low at 72 h, but the level increased at 144 h in uterus.

  2. correlation was observed between CT perfusion parameters (BF, BV, PS, and MAV (Montrer KLHL2 Anticorps)) and expression of VEGF and MVD (Montrer MVD Anticorps) in tumor tissue

  3. Physiologic ischemic training stimulates VEGF-mediated mobilization of endothelial progenitor cells as well as angiogenesis.

  4. Suggest supplemental oxygen inhibits HIF-1alpha/VEGF signaling to reduce smooth muscle proliferation in rabbit arteriovenous fistula model.

  5. Therefore, it was reasonable to speculate that the increased expression of VEGF and MMP-9 (Montrer MMP9 Anticorps) in residual hepatic tumor cells and tumor angiogenesis post-embolization would be responsible for the increased metastatic potentiality and invasiveness.

  6. VEGF expression peaked at 8 weeks after meniscus transplantation

  7. Studied the biocompatibility and neovascularization of the PLGA nanospheres wrapped with vascular endothelial growth factor (VEGF).

  8. VEGF induces TGF-beta1 (Montrer TGFB1 Anticorps) expression and myofibroblast transformation after glaucoma surgery.

  9. The results of this study are promising concerning the role of VEGF as a diagnostic marker in moderate osteoarthritis

  10. The overexpression of VEGF increased tumor growth and vascularization, favored cyst formation, and reduced tumor necrosis.

Rhesus Monkey Vascular Endothelial Growth Factor A (VEGFA) interaction partners

  1. VEGF plays an important role in choroid-retinal endothelial cell proliferation and tube formation.

  2. These findings suggest that FBLN5 (Montrer FBLN5 Anticorps) may interfere with choroidal neovascularization by downregulating VEGF, CXCR4 (Montrer CXCR4 Anticorps), and TGFB1 (Montrer TGFB1 Anticorps) expression and inhibiting choroidl endothelial cell proliferation.

  3. Apelin may play a role in the development of central retinal vein occlusion (CRVO). Apelin has a unique upstream signaling pathway, independent of the VEGF pathway.

  4. Dll4 play an important role in choroidal neovascularization (CNV) angiogenesis, which appears to be regulated by HIF-1alpha and VEGF during the progression of CNV under hypoxic conditions.

  5. A functional network involving VEGF, IGF2, and MMP9 (Montrer MMP9 Anticorps) in early placental trophoblast cells and maternal endometrium appears to be important for normal placentation.

VEGF (VEGFA) profil antigène

Antigen Summary

This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.

Alternative names and synonyms associated with VEGF (VEGFA)

  • vascular endothelial growth factor Aa (vegfaa) anticorps
  • vascular endothelial growth factor A (vegfa-a) anticorps
  • vascular endothelial growth factor A (VEGFA) anticorps
  • vascular endothelial growth factor A (vegfa) anticorps
  • vascular endothelial growth factor A (Vegfa) anticorps
  • eVEGF120 anticorps
  • eVEGF164 anticorps
  • MVCD1 anticorps
  • vefg anticorps
  • Vegf anticorps
  • VEGF-A anticorps
  • Vegf120 anticorps
  • VEGF164 anticorps
  • Vegf188 anticorps
  • vegfa anticorps
  • Vpf anticorps
  • wu:fj82c06 anticorps

Protein level used designations for VEGFA

VEGF-A-A , etID309976.16 , vascular endothelial growth factor A , vascular endothelial growth factor A-A , vegf-a , vascular endothelial growth factor A-a , vascular endothelial growth factor 164 , vascular permeability factor , VEGF-A , VPF , vascular endothelial growth factor 188 , angiogenic factor , Vascular permeability factor , endothelial growth factor-164 , vascular endothelial growth factor VEGF

GENE ID SPECIES
30682 Danio rerio
373589 Xenopus laevis
493845 Felis catus
100038089 Xenopus (Silurana) tropicalis
281572 Bos taurus
7422 Homo sapiens
22339 Mus musculus
83785 Rattus norvegicus
397157 Sus scrofa
403802 Canis lupus familiaris
395909 Gallus gallus
100033839 Equus caballus
443103 Ovis aries
100713483 Cavia porcellus
100860957 Capra hircus
100008899 Oryctolagus cuniculus
101839822 Mesocricetus auratus
574209 Macaca mulatta
Fournisseurs de qualité sélectionnés pour anti-VEGF (VEGFA) Anticorps
Avez-vous cherché autre chose?